Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort Study

Rhinology

Volumn 48, Issue 2, 2010, Pages 201-205

  Del Cuvillo, Alfonso ^a   Montoro, Javier ^b   Bartra, Joan ^c,d   Antonio Valero, ^c,d   Marta Ferrer, ^e   Ignacio Jauregui ^f   Ignacio Davila ^g   Joaquin Sastre ^d,h   Joaquim Mullol, ^d,i  

^a Clinica Dr Lobaton   (Spain)

^b HOSPITAL DE LA PLANA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f HOSPITAL DE BASURTO   (Spain)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h Hospital UniversitarioFundación Jiménez Díaz   (Spain)

ⁱ INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Allergic rhinitis; ARIA; EpiDemiology; Quality of life; Severity

Indexed keywords

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; CONJUNCTIVITIS; CROSS-SECTIONAL STUDY; FEMALE; HAY FEVER; HOSPITALIZATION; HUMAN; MALE; MULTICENTER STUDY; NONPARAMETRIC TEST; PERENNIAL RHINITIS; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; STATISTICAL MODEL; VALIDATION STUDY;

ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONJUNCTIVITIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 77952987621     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhin09.099     Document Type: Article

References (24)

1. Asher MI, Montefort S, Bjorksten B, et al. WorldwiDe time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008; 63: 8-160. (Pubitemid 351357811)
3. Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000; 55: 116-134. (Pubitemid 30106016)
4. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005; 60: 882-887.
5. Bauchau V, Durham SR. EpiDemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60: 350-353.
6. Ciprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995; 96: 971-979.
7. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-334.
8. Mullol J, Valero A, Alobid I, et al. Allergic Rhinitis and its Impact on Asthma update (ARIA 2008). The perspective from Spain. J Investig Allergol Clin Immunol 2008; 18: 327-334.
9. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58: 672-675.
10. Bousquet J, Neukirch F, Bousquet PJ, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006; 117: 158-162.
11. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, Van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol 2006; 118: 758-759.
12. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moDerate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol 2007; 120: 359-365.
13. Bousquet J, Lund VJ, Van Cauwenberge P, et al. Implementation of guiDelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 2003; 58: 733-741.
14. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83.
15. De Blic J, Wahn U, Billard E, Alt R, Pujazon M-C. Levocetirizine in children: eviDenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol 2005; 16: 267-275.
16. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graDed according to ARIA guiDelines. Allergy 2007; 62: 367-372.
17. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996; 98: 843-845.
18. Soler R, De la Hoz B, Badia X, et al. [Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)]. Rev Clin Esp 2004; 204: 131-138.
19. Bachert C, Van Cauwenberge P, Olbrecht J, Van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006; 61: 693-698.
20. Bousquet J, Annesi-Maesano I, Carat F, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005; 35: 728-732.
21. Pereira C, Valero A, Loureiro C, et al. Iberian study of aeroallergens sensitisation in allergic rhinitis. Eur Ann Allergy Clin Immunol 2006; 38: 186-194.
22. Van Hoecke H, Vastesaeger N, Dewulf L, Sys L, Van Cauwenberge P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy 2006; 61: 705-711.
23. Leynaert B, Neukirch C, Kony S, et al. Association between asthma and rhinitis according to atopic sensitization in a populationbased study. J Allergy Clin Immunol 2004; 113: 86-93.
24. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an inDepenDent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109: 419-425.